Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (371-380 of 592) with videos related to

Pageof 60
Sort By:
Alimentary Pharmacology & Therapeutics|July 16, 2013
Genetic risk factors for Clostridium difficile infection in ulcerative colitisA N Ananthakrishnan, E C Oxford, D D Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 6, 2017
Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to VaccinesDawn B Beaulieu, Ashwin N Ananthakrishnan, Christopher Martin, et al.
Journal of Crohn'S & Colitis|March 20, 2019
Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel DiseasesNienke Z Borren, Jay Luther, Francis P Colizzo, et al.
Digestive Diseases and Sciences|June 29, 2018
Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative ColitisAmar Vedamurthy, Louise Xu, Jay Luther, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2019
Association Between Vulvovaginal Discomfort and Activity of Inflammatory Bowel DiseasesSamsiya Ona, Kaitlyn James, Ashwin N Ananthakrishnan, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2012
Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel diseaseP S A de Silva, D D Nguyen, J Sauk, et al.
The American Journal of Gastroenterology|April 7, 2025
Existential Reflections by Older Adults With Inflammatory Bowel Diseases on Medical and Surgical TreatmentsAlison Rusher, Alexandra Fuss, Elizabeth Araka, et al.
Inflammatory Bowel Diseases|February 23, 2013
Early life factors and risk of inflammatory bowel disease in adulthoodHamed Khalili, Ashwin N Ananthakrishnan, Leslie M Higuchi, et al.
Inflammatory Bowel Diseases|May 19, 2017
Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel DiseaseNienke Z Borren, Grace Conway, William Tan, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|December 1, 1995
Tropical vaginal hydroceles: are they all filarial in origin?N S Sivam, S Jayanthi, N Ananthakrishnan, et al.
Pageof 60

Showing results (371-380 of 592) with videos related to

Sort By:
Pageof 60
Alimentary Pharmacology & Therapeutics|July 16, 2013
Genetic risk factors for Clostridium difficile infection in ulcerative colitisA N Ananthakrishnan, E C Oxford, D D Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 6, 2017
Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to VaccinesDawn B Beaulieu, Ashwin N Ananthakrishnan, Christopher Martin, et al.
Journal of Crohn'S & Colitis|March 20, 2019
Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel DiseasesNienke Z Borren, Jay Luther, Francis P Colizzo, et al.
Digestive Diseases and Sciences|June 29, 2018
Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative ColitisAmar Vedamurthy, Louise Xu, Jay Luther, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2019
Association Between Vulvovaginal Discomfort and Activity of Inflammatory Bowel DiseasesSamsiya Ona, Kaitlyn James, Ashwin N Ananthakrishnan, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2012
Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel diseaseP S A de Silva, D D Nguyen, J Sauk, et al.
The American Journal of Gastroenterology|April 7, 2025
Existential Reflections by Older Adults With Inflammatory Bowel Diseases on Medical and Surgical TreatmentsAlison Rusher, Alexandra Fuss, Elizabeth Araka, et al.
Inflammatory Bowel Diseases|February 23, 2013
Early life factors and risk of inflammatory bowel disease in adulthoodHamed Khalili, Ashwin N Ananthakrishnan, Leslie M Higuchi, et al.
Inflammatory Bowel Diseases|May 19, 2017
Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel DiseaseNienke Z Borren, Grace Conway, William Tan, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|December 1, 1995
Tropical vaginal hydroceles: are they all filarial in origin?N S Sivam, S Jayanthi, N Ananthakrishnan, et al.
Pageof 60